Cancer research advances in Spain through nanotechnology and translational science

Researchers in Spain are advancing cancer treatment through nanotechnology and translational science. At the Institute for Bioengineering of Catalonia (IBEC) in Barcelona, researcher David Esporrín is working on a project to develop tiny nanomotors. These motors are designed to travel to bladder tumors, penetrate them, and use infrared lasers to generate heat and destroy the tumor locally, minimizing damage to healthy tissue. This research is supported by a four-year postdoctoral grant from the Spanish Association Against Cancer (AECC).

In a related effort to bridge the gap between laboratory science and clinical practice, the FERO Cancer Foundation is marking 25 years of supporting translational research. Founded by Dr. Josep Baselga, the foundation has invested over 30 million euros in scientific advancement. Its work focuses on moving laboratory discoveries into patient care, primarily through the Vall d’Hebron Institute of Oncology (VHIO), a leading center for oncological research in Spain.